Pharma industry likely to grow to $130 billion by 2030: Industry leaders
- IBEF
- February 28, 2022
According to industry leaders, the country's pharmaceutical business might rise to US$ 130 billion by 2030. Business leaders attended a 'CEOs Conclave' as part of the Telangana government's flagship annual life sciences convention, 'BioAsia 2022,' which ended on Friday.
Regarding the US$ 130 billion estimates, Sun Pharma Managing Director Mr. Dilip Shanghvi said: "I think if all the players, I see their level of excitement and the sense about future, I think we should be on the way to achieve that kind of a number." He also added that "As India becomes an increasingly more important component for the global supply chain, that should benefit the industry going forward. Various measures taken by the government should also further strengthen our ability to compete. I am quite optimistic."
Disclaimer: This information has been collected through secondary research and IBEF is not responsible for any errors in the same.
Partners
